UnitedHealth Group Incorporated (NYSE:UNH) went down by -0.48% from its latest closing price compared to the recent 1-year high of $431.36. The company’s stock price has collected -2.07% of loss in the last five trading sessions. MarketWatch.com reported on 09/10/21 that U.S. stocks close lower, as Dow, S&P 500 and Nasdaq book weekly losses
Is It Worth Investing in UnitedHealth Group Incorporated (NYSE :UNH) Right Now?
UnitedHealth Group Incorporated (NYSE:UNH) scored a price-to-earnings ratio above its average ratio, recording 27.24 x from its present earnings ratio. Plus, the 36-month beta value for UNH is at 0.77. Opinions of the stock are interesting as 22 analysts out of 27 who provided ratings for UnitedHealth Group Incorporated declared the stock was a “buy,” while 1 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $466.83, which is $45.58 above the current price. UNH currently public float of 937.38M and currently shorts hold a 0.68% ratio of that float. Today, the average trading volume of UNH was 2.79M shares.
UNH’s Market Performance
UNH stocks went down by -2.07% for the week, with a monthly jump of 0.70% and a quarterly performance of 3.06%, while its annual performance rate touched 33.69%. The volatility ratio for the week stands at 2.20% while the volatility levels for the past 30 days are set at 1.62% for UnitedHealth Group Incorporated. The simple moving average for the period of the last 20 days is -1.61% for UNH stocks with a simple moving average of 8.56% for the last 200 days.
Analysts’ Opinion of UNH
Many brokerage firms have already submitted their reports for UNH stocks, with Cowen repeating the rating for UNH by listing it as a “Outperform.” The predicted price for UNH in the upcoming period, according to Cowen is $478 based on the research report published on September 10th of the current year 2021.
Seaport Global Securities, on the other hand, stated in their research note that they expect to see UNH reach a price target of $450. The rating they have provided for UNH stocks is “Buy” according to the report published on July 09th, 2021.
BofA Securities gave a rating of “Buy” to UNH, setting the target price at $522 in the report published on June 01st of the current year.
UNH Trading at -0.79% from the 50-Day Moving Average
After a stumble in the market that brought UNH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.36% of loss for the given period.
Volatility was left at 1.62%, however, over the last 30 days, the volatility rate increased by 2.20%, as shares sank -1.12% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.78% upper at present.
During the last 5 trading sessions, UNH fell by -2.07%, which changed the moving average for the period of 200-days by +23.82% in comparison to the 20-day moving average, which settled at $419.07. In addition, UnitedHealth Group Incorporated saw 17.64% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at UNH starting from HEMSLEY STEPHEN J, who sale 70,000 shares at the price of $426.30 back on Aug 23. After this action, HEMSLEY STEPHEN J now owns 621,560 shares of UnitedHealth Group Incorporated, valued at $29,841,154 using the latest closing price.
REX JOHN F, the EVP Chief Financial Officer of UnitedHealth Group Incorporated, sale 15,438 shares at $412.04 during a trade that took place back on Jul 29, which means that REX JOHN F is holding 117,149 shares at $6,361,027 based on the most recent closing price.
Stock Fundamentals for UNH
Current profitability levels for the company are sitting at:
- +8.71 for the present operating margin
The net margin for UnitedHealth Group Incorporated stands at +5.99. The total capital return value is set at 19.82, while invested capital returns managed to touch 14.94. Equity return is now at value 21.80, with 7.20 for asset returns.
Based on UnitedHealth Group Incorporated (UNH), the company’s capital structure generated 74.48 points at debt to equity in total, while total debt to capital is 42.69. Total debt to assets is 24.31, with long-term debt to equity ratio resting at 65.80. Finally, the long-term debt to capital ratio is 37.71.
When we switch over and look at the enterprise to sales, we see a ratio of 1.52, with the company’s debt to enterprise value settled at 0.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.74.